KURA (KURA) Stock Price & Analysis
KURA (KURA) rose 0.76% to USD 13.25 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
KURA last closed at USD 13.25; the session ranged USD 12.89–13.27 on volume of 1,313,519 shares. Market capitalization is —, with a 52-week range of USD 7.36–13.9 (NMS). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 13.25 |
|---|---|
| Change | ▲ 0.76% (up) |
| Previous Close | USD 13.25 |
| Open | USD 13.25 |
| Day Range | USD 12.89 – 13.27 |
| 52-Week Range | USD 7.36 – 13.9 |
| Volume | 1,313,519 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KURA)
Nexqual's technical model rates KURA "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 63.71 (neutral) |
| vs SMA50 | Above (USD 11.11) |
| MACD | 0.75 (positive) |
From KURA's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.56 | ▼ 1.06% |
| ANAB | AnaptysBio, Inc. | USD 56.8 | ▲ 1.72% |
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| PTGX | Protagonist Therapeutics, Inc. | USD 145.72 | ▼ 0.25% |
| XNCR | Xencor, Inc. | USD 26.61 | ▼ 1.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.